Does intracoronary thrombus influence the outcome of high risk percutaneous transluminal coronary angioplasty? Clinical and angiographic outcomes in a large multicenter trial. EPIC Investigators. Evaluation of IIb/IIIa Platelet Receptor Antagonist 7E3 in Preventing Ischemic Complications.

[1]  L. Badimón,et al.  Syndromes of Accelerated Atherosclerosis , 1999 .

[2]  P. Serruys,et al.  Role of angiographically identifiable thrombus on long-term luminal renarrowing after coronary angioplasty: a quantitative angiographic analysis. , 1996, Circulation.

[3]  P. Teirstein,et al.  Coronary thrombi increase PTCA risk. Angioscopy as a clinical tool. , 1996, Circulation.

[4]  E. Topol.  Prevention of cardiovascular ischemic complications with new platelet glycoprotein IIb/IIIa inhibitors. , 1995, American heart journal.

[5]  P. Teirstein,et al.  Angioscopic versus angiographic detection of thrombus during coronary interventional procedures. , 1995, The American journal of cardiology.

[6]  C. White,et al.  Coronary angioscopy of abrupt occlusion after angioplasty. , 1995, Journal of the American College of Cardiology.

[7]  B. Uretsky,et al.  Angioscopic evaluation of incompletely obstructing coronary intraluminal filling defects: comparison to angiography. , 1994, Catheterization and cardiovascular diagnosis.

[8]  P. Serruys,et al.  Serial angioscopic and angiographic observations during the first hour after successful coronary angioplasty: a preamble to a multicenter trial addressing angioscopic markers for restenosis. , 1994, American heart journal.

[9]  P. Serruys,et al.  Angioscopic versus angiographic detection of intimal dissection and intracoronary thrombus. , 1994, Journal of the American College of Cardiology.

[10]  W. Roberts,et al.  Coronary arteries in unstable angina pectoris, acute myocardial infarction, and sudden coronary death. , 1994, American heart journal.

[11]  R. Califf,et al.  Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months , 1994, The Lancet.

[12]  Epic Investigators,et al.  Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. , 1994, The New England journal of medicine.

[13]  A. Kurita,et al.  Angioscopy, coronary thrombi and acute coronary syndromes. , 1993, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[14]  W. Laskey,et al.  Management and immediate outcome of patients with intracoronary thrombus during percutaneous transluminal coronary angioplasty. , 1992, American heart journal.

[15]  E. Topol,et al.  Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile. , 1992, Journal of the American College of Cardiology.

[16]  D. Waters,et al.  Quantitative Angiographic Morphology of the Coronary Artery Lesions at Risk of Thrombotic Occlusion , 1992, Circulation.

[17]  B. Pitt,et al.  A Monoclonal Antibody Against the Platelet Glycoprotein IIb/IIIa Receptor Complex Prevents Platelet Aggregation and Thrombosis in a Canine Model of Coronary Angioplasty , 1991, Circulation.

[18]  W. Roberts,et al.  Morphologic comparison of frequency and types of acute lesions in the major epicardial coronary arteries in unstable angina pectoris, sudden coronary death and acute myocardial infarction. , 1991, Journal of the American College of Cardiology.

[19]  E. Topol,et al.  Prospects for the use of antagonists to the platelet glycoprotein IIb/IIIa receptor to prevent post-angioplasty restenosis and thrombosis. , 1991, Journal of the American College of Cardiology.

[20]  V. Fuster,et al.  The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty. , 1991, Journal of the American College of Cardiology.

[21]  R. Califf,et al.  Restenosis after coronary angioplasty: an overview. , 1991, Journal of the American College of Cardiology.

[22]  P. Serruys,et al.  Acute Coronary Artery Occlusion During and After Percutaneous Transluminal Coronary Angioplasty: Frequency, Prediction, Clinical Course, Management, and Follow‐up , 1991, Circulation.

[23]  D. Faxon,et al.  Incidence and consequences of periprocedural occlusion. The 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. , 1990, Circulation.

[24]  V. Fuster,et al.  Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. , 1990, Journal of the American College of Cardiology.

[25]  R. V. Van Tassel,et al.  Percutaneous transluminal coronary angioplasty in the setting of large intracoronary thrombi. , 1990, The American journal of cardiology.

[26]  M. Onofri,et al.  Management of complicated coronary angioplasty by intracoronary urokinase and immediate re-angioplasty. , 1990, Catheterization and cardiovascular diagnosis.

[27]  W. Laskey,et al.  Influence of heparin therapy on percutaneous transluminal coronary angioplasty outcome in patients with coronary arterial thrombus. , 1990, The American journal of cardiology.

[28]  Spencer B. King,et al.  Restenosis After Coronary Angioplasty: Potential Biologic Determinants and Role of Intimal Hyperplasia , 1989 .

[29]  C. Simpfendorfer,et al.  Role of intracoronary thrombus in acute complications during percutaneous transluminal coronary angioplasty. , 1989, Catheterization and cardiovascular diagnosis.

[30]  G. Vetrovec,et al.  Angiographic observations and clinical relevance of coronary thrombus in unstable angina pectoris. , 1989, The American journal of cardiology.

[31]  M. Kern,et al.  Percutaneous transluminal coronary angioplasty in patients with intracoronary thrombus. , 1988, The American journal of cardiology.

[32]  L. Hillis,et al.  Restenosis after successful coronary angioplasty. Pathophysiology and prevention. , 1988, The New England journal of medicine.

[33]  H. Gold,et al.  Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs. , 1988, The Journal of clinical investigation.

[34]  S. Ellis,et al.  Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. , 1988, Circulation.

[35]  V. Fuster,et al.  Restenosis after arterial angioplasty: a hemorrheologic response to injury. , 1987, The American journal of cardiology.

[36]  D. Holmes,et al.  Coronary artery thrombus as a risk factor for acute vessel occlusion during percutaneous transluminal coronary angioplasty: improving results. , 1986, British heart journal.

[37]  D. Holmes,et al.  Intracoronary thrombus: role in coronary occlusion complicating percutaneous transluminal coronary angioplasty. , 1985, Journal of the American College of Cardiology.

[38]  B. Coller,et al.  A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa. , 1983, The Journal of clinical investigation.